FDA to launch advisory committee on digital health technologies
The Food and Drug Administration will accept nominations through Dec. 11 for experts to serve on a committee that will advise the agency on issues related to digital health technologies, from artificial intelligence/machine learning and digital therapeutics to wearables and remote patient monitoring.
“Many of these technologies are novel and tend to rapidly change; it’s our duty to seek as much knowledge on them as possible as we determine and implement appropriate regulation to encourage innovation while protecting public health,” said Troy Tazbaz, director of the FDA’s Digital Health Center of Excellence.
Related News Articles
Headline
A new critical vulnerability has been discovered in Citrix NetScaler ADC and NetScaler Gateway products, the company announced Oct 8. Citrix said the…
Chairperson's File
What does patient safety mean to you? For many, patient safety means what we can see: hand hygiene, infection prevention and control practices, medication…
Headline
A joint advisory released Oct. 8 by U.S. and international agencies warns of Chinese government-linked cyber threat actors using automated and hands-on hacking…
Headline
The National Security Agency Oct. 8 released guidance for critical infrastructure organizations that recommends adopting high-impact zero trust strategies to…
Headline
The Agency for Healthcare Research and Quality Oct. 7 announced the launch of the Super Intelligence for Healthcare Improvement Initiative, a two-part…
Headline
The FBI and Secret Service released an advisory Oct. 6 warning of ongoing activities by FortiBleed, a global credential-compromise campaign used by threat…